Cystatin C: New Clinical Chemistry Parameter Available For DRG:HYBRiD-XL

Sep 24, 2014Products

DRG is glad to announce the next release of a clinical chemistry assay. Cystatin C is the latest released parameter for DRG:HYBRiD-XL and is ready to be purchased!

Cystatin C: New clinical chemistry parameter available for DRG:HYBRiD-XL

DRG is glad to announce the next release of a clinical chemistry assay. Cystatin C is the latest released parameter forDRG:HYBRiD-XL and is ready to be purchased!

The assay includes 80 tests and has an incubation time of 10 min in total.

You may order with the following catalog number:

Cystatin C HYC-5320

[starbox]

News and Updates

Estimating the Burden of Iron Deficiency

Estimating the Burden of Iron Deficiency

  Background: Iron deficiency (ID) is a major public health burden in African children and accurate prevalence   Abstract Background and Objective Iron deficiency (ID) is a major public health burden in African children and accurate prevalence estimates are...

read more
Click the link to learn more about how DRG is certified in the manufacturing and distribution of in-vitro diagnostic reagents used in the diagnosis of autoimmune status, cancer, cardiac markers, disease status, fertility testing, pregnancy testing, diabetes and immune status.